ursodeoxycholic acid has been researched along with Intestinal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballestero, MR; Briz, O; Marin, JJ; Monte, MJ; Perez, MJ | 1 |
| Invernizzi, P; O'Connor, M; Salzman, AL; Setchell, KD; Szabó, C; Ueta, I | 1 |
2 other study(ies) available for ursodeoxycholic acid and Intestinal Neoplasms
| Article | Year |
|---|---|
Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Adducts; DNA Fragmentation; Humans; Intestinal Neoplasms; Intestine, Small; Male; Mice; Necrosis; Organoplatinum Compounds; Ursodeoxycholic Acid | 2005 |
Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo.
Topics: Adenocarcinoma; Animals; Cell Line, Transformed; Cell Survival; Enzyme Induction; Enzyme Repression; Humans; Intestinal Mucosa; Intestinal Neoplasms; Kinetics; Lipopolysaccharides; Mitochondria; Molsidomine; Nitrates; Nitric Oxide Synthase; Nitrites; Oxygen Consumption; Rats; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1997 |